ÁÖÁ¦º°°Ë»ö
(current)
Å°¿öµå°Ë»ö
(±¸)µ¥ÀÌÅÍ°Ë»ö
¾÷µ¥ÀÌÆ®Á¤º¸
°ü·Ã»çÀÌÆ®
COVID-19, A Clinical Syndrome Manifesting as Hypersensitivity Pneumonitis
Infection & Chemotherapy
2020³â 52±Ç 1È£ p.110 ~ p.112
¼Û¿µ±¸
(Song Young-Goo) - Yonsei University College of Medicine Gangnam Severance Hospital Department of Internal Medicine
½ÅÇü½Ä
(Shin Hyoung-Shik) - National Medical Center Department of Internal Medicine
Abstract
Å°¿öµå
COVID-19, Coronavirus, SARS-CoV-2, Hypersensitivity pneumonitis
KMID :
1144320200520010110
doi.org/10.3947/ic.2020.52.1.110
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
Radiology and pathology examinations of patients with COVID-19 revealed inflammatory reactions in the lung that resembled what is observed in hypersensitivity pneumonitis rather than in other viral pneumonia.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
doi.org/10.3947/ic.2020.52.1.110
KCDÄÚµå
ICD 03
°Ç°º¸ÇèÄÚµå